Scarica l'app Stockscreener
8.01
4.35%
0.31
Dopo l'orario di chiusura:
8.01
Inmune Bio Inc Borsa (INMB) Ultime notizie
INmune Bio: Imminent Phase 2 Alzheimer's Readout Of Unique Asset Presents Interesting Speculative Opportunity - Seeking Alpha
INmune Bio, Inc. (NASDAQ:INMB) Shares Bought by Two Sigma Investments LP - Defense World
(INMB) On The My Stocks Page - news.stocktradersdaily.com
INmune Bio Collaborates on TBI and Alzheimer’s Study - TipRanks
INmune Bio, Inc. Collaborates on Study Showing XPro™ Treatment Reduces Alzheimer’s-like Pathology After Traumatic Brain Injury in Mice - Nasdaq
XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer's Disease: Supported by Department of Defense - The Manila Times
Xpro(TM) Reduces Amyloid And Enhances Behavior Post - marketscreener.com
Breakthrough: New Drug Reduces Alzheimer's Risk After Brain Injury, DoD-Backed Study Shows - Stock Titan
Two Sigma Advisers LP Takes Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
Lucid Capital Markets initiates Buy rating for INmune Bio stock - Investing.com India
Lucid Capital Markets initiates Buy rating for INmune Bio stock By Investing.com - Investing.com Nigeria
INMB Stock Set for Growth with Positive Analyst Coverage | INMB Stock News - GuruFocus
Millennium Management LLC Boosts Stake in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
Are You MINDFuL Of INmune Bio's Upcoming Alzheimer's Trial Readout? - RTTNews
Northern Trust Corp Acquires 9,154 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World
BNP Paribas Financial Markets Has $119,000 Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
When (INMB) Moves Investors should Listen - news.stocktradersdaily.com
Where are the Opportunities in (INMB) - news.stocktradersdaily.com
Dimensional Fund Advisors LP Acquires 10,491 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World
INmune Bio: XPro Trial Readout In Alzheimer’s Disease Offers Big Opportunity (NASDAQ:INMB) - Seeking Alpha
Wells Fargo & Company MN Buys 2,155 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World
INmune Bio to Attend RBC Healthcare Conference - TipRanks
INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times
INmune Bio Sets Stage for Key Biotech Insights at RBC Healthcare Conference Next Week - Stock Titan
Raymond James raises INmune Bio stock target to $23 - MSN
Barclays PLC Increases Stake in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN
INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey
INmune Bio’s Earnings Call: Promise and Challenges - TipRanks
Mariner LLC Acquires New Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
Earnings call transcript: INmune Bio Q1 2025 shows narrowed losses, stock rises - Investing.com
INmune Bio Reports Q1 2025 Results and Updates - TipRanks
INMUNE BIO Earnings Results: $INMB Reports Quarterly Earnings - Nasdaq
INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - The Manila Times
(INMB) Trading Signals - news.stocktradersdaily.com
INmune Bio appoints new accounting firm By Investing.com - Investing.com Nigeria
INmune Bio appoints new accounting firm - Investing.com
INmune Bio Inc (INMB) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
JPMorgan Chase & Co. Has $53,000 Stock Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
INmune Bio Inc expected to post a loss of 47 cents a shareEarnings Preview - TradingView
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - The Manila Times
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on ... - Eagle-Tribune
Renaissance Technologies LLC Increases Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
LPL Financial LLC Boosts Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
INmune Bio, Inc. (NASDAQ:INMB) Receives $22.80 Average PT from Analysts - Defense World
INmune Bio (INMB) Expected to Announce Quarterly Earnings on Thursday - Defense World
Geode Capital Management LLC Has $1.70 Million Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World
A stock that deserves closer examination: INmune Bio Inc (INMB) - uspostnews.com
(INMB) Technical Data - news.stocktradersdaily.com
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Inmune Bio Secures Favorable Patentability Opinion for CORDStrom™ - TipRanks
INmune Bio secures key patent opinion for CORDStrom platform By Investing.com - Investing.com South Africa
INmune Bio Receives Favorable Opinion from USPTO on CORDStrom Patent Application - marketscreener.com
5.04%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):